Concourse Financial Group Securities, Inc. Beyond Air, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$0.54 - $1.67 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.3 - $2.15 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.4 - $2.46 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$2.31 - $4.18 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$2.31 - $4.18 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$4.26 - $6.92 $0 - $0
Q1 2023 May 15, 2023	BUY	$5.65 - $7.56 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$5.47 - $7.9 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$7.42 - $11.39 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$4.96 - $7.83 $0 - $0
Q1 2022 May 09, 2022	BUY	$6.33 - $9.53 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$8.44 - $15.61 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$5.9 - $12.54 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$4.72 - $7.15 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.13 - $7.24 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$5.18 - $6.03 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.86 - $7.07 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$6.44 - $9.45 $0 - $0
Q1 2020 May 13, 2020	BUY	$3.94 - $10.93 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.57 - $5.23 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.17 - $5.89 $0 - $0

Others Institutions Holding XAIR

# of Institutions

Shares Held

11.2M

Call Options Held

54.4K

Put Options Held

Aigh Capital Management LLC Baltimore, MD

3.64M
Shares

$1.38 Million
0.71% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

1.36M
Shares

$516,102
0.09% of portfolio
Vanguard Group Inc Valley Forge, PA

1.26M
Shares

$480,515
0.0% of portfolio
Adar1 Capital Management, LLC Austin, TX

1.23M
Shares

$465,602
0.12% of portfolio
Black Rock Inc. New York, NY

519K
Shares

$197,214
0.0% of portfolio

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $11.4M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account